PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login Register FREE

CEOP-B protocol

Subscribe to Selected New Research on CEOP-B protocol

4 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: a chemotherapy protocol consisting of the above compounds; used in the treatment of non-Hodgkin's lymphoma

Also Known As:

CEOP-Bleo

Bio-Agent Context: Research Results

-

Therapeutics: 5195

-

Drug Therapy: 116609

-

Combination Drug Therapy: 8322

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

CEOP-B protocol: 4

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

CEOP-B protocol: 4

-

Clinical Protocols

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

CEOP-B protocol: 4

-

Carbohydrates: 2946

-

Glycoconjugates: 631

-

Glycopeptides: 480

-

Bleomycin: 5151

*

CEOP-B protocol: 4

-

Glycosides: 339

-

Aminoglycosides: 1075

-

Anthracyclines: 1290

-

Daunorubicin: 1725

-

Doxorubicin: 15007

-

Epirubicin: 2010

*

CEOP-B protocol: 4

-

Amino Acids, Peptides, and Proteins

-

Peptides: 16074

-

Glycopeptides: 480

-

Bleomycin: 5151

*

CEOP-B protocol: 4

-

Polycyclic Compounds: 58

-

Steroids: 13691

-

-

-

Pregnadienediols

-

Prednisone: 7159

*

CEOP-B protocol: 4

-

Aromatic Polycyclic Hydrocarbons: 581

-

-

Anthracyclines: 1290

-

Daunorubicin: 1725

-

Doxorubicin: 15007

-

Epirubicin: 2010

*

CEOP-B protocol: 4

-

Heterocyclic Compounds: 23

-

-

Indole Alkaloids: 21

-

Secologanin Tryptamine Alkaloids: 49

-

Vinca Alkaloids: 279

-

Vincristine: 5619

*

CEOP-B protocol: 4

-

2-Ring Heterocyclic Compounds

-

-

Indole Alkaloids: 21

-

Secologanin Tryptamine Alkaloids: 49

-

Vinca Alkaloids: 279

-

Vincristine: 5619

*

CEOP-B protocol: 4